AbbVie Revenue, Profits - ABBV Quarterly Income Statement

Add to My Stocks
$92.68 $1.66 (1.82%) ABBV stock closing price Sep 20, 2018 (Closing)

Looking at financial statements, along with the AbbVie stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement for ABBV which shows a YOY revenue growth of 4.34% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. One also needs to look at AbbVie assets, operating expenses and AbbVie free cash flow. The AbbVie profit and loss statement shows revenue of $8.28B for 2018 Q2. Revenue has grown by 4.34% QoQ for ABBV stock.

View and download details of revenue and profits for AbbVie for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
AbbVie Revenues or Net Sales
8.28B7.93B7.74B7B6.94B6.54B6.8B6.43B6.45B5.96B
Cost Of Goods Sold (COGS)1.93B1.93B2.28B1.62B1.53B1.62B1.56B1.5B1.41B1.37B
AbbVie Gross Profit
6.34B6.01B5.46B5.38B5.42B4.92B5.24B4.93B5.05B4.59B
Research & Development Expense1.32B1.31B1.71B1.22B1.24B1.14B1.23B1.19B1.19B956M
Selling General & Admin Expense2.26B1.79B1.95B1.45B1.5B1.37B1.65B1.38B1.47B1.36B
Income Before Depreciation Depletion Amortization2.76B2.9B1.79B2.71B2.67B2.42B2.36B2.36B2.39B2.28B
Depreciation Depletion Amortization----------
Non Operating Income-478M145M-349M-358M-68M-86M-70M-97M-66M-302M
Interest Expense272M251M252M252M253M247M290M250M225M200M
AbbVie Pretax Income
2.01B2.8B1.19B2.1B2.35B2.09B2B2.01B2.1B1.78B
Provision for Income Taxes29M14M1.14B464M438M375M607M416M486M422M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations1.98B2.78B52M1.63B1.92B1.71B1.39B1.6B1.61B1.35B
Extraordinary Items & Discontinued Operations----------
AbbVie Profit/ Loss (Net Income)
1.98B2.78B52M1.63B1.92B1.71B1.39B1.6B1.61B1.35B
Average Shares used to compute Diluted EPS1.57B1.6B1.6B1.6B1.6B1.6B1.62B1.64B1.63B1.63B
Average Shares used to compute Basic EPS1.57B1.6B1.6B1.6B1.6B1.6B1.62B1.64B1.63B1.63B
Income Before Nonrecurring Items3.17B3B2.39B2.27B2.29B2.06B1.96B1.99B2.07B1.87B
Income from Nonrecurring Items-1.18B-217M-2.34B-642M-374M-349M-573M-396M-462M-520M
AbbVie Earnings Per Share Basic Net
1.261.740.031.011.191.060.850.970.980.83
AbbVie Earnings Per Share Diluted Net
1.261.740.031.011.191.060.850.970.980.83
EPS Diluted Before Nonrecurring Items2.001.871.481.411.421.281.201.211.261.15
Preferred Dividends Acc Pd----------
Dividends Common1523.411126.691021.72-------
Dividend Per Share Common0.960.710.640.640.640.640.570.570.570.57
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on AbbVie stock analysis. It helps to look at the following income statement items:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $8.28B for this quarter of 2018 Q2. Our AbbVie revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $1.98B for ABBV stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the ABBV income statement, one can check the AbbVie historical stock prices to check how the price has moved with time.

AbbVie Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
22.53
PS Ratio (price sales ratio)
4.62
Operating Margin
33.4
Net Profit Margin
24
Dividend Yield
3.24%